Executives
?
Patience David
Chief Financial Officer
Accelerate Diagnostics, Inc.
US, Tucson [HQ]
CIK
1970009
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
8,794
Price per Share :
$1.05
Equivalence :
$9,233.70
Transaction History
-
M8,794 Shares After TransactionValue : $n/a$0.0Transaction Date : 11/13/23
-
Footnotes
-
-
Footnotes:#1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
-
S8,697 Shares After TransactionValue : $48,442.29Sold $540.29Transaction Date : 11/13/23
-
Footnotes
-
-
Footnotes:#1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
-
M8,559 Shares After TransactionValue : $n/a$0.0Transaction Date : 10/13/23
-
Footnotes
-
-
Footnotes:#1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
-
S8,463 Shares After TransactionValue : $49,339.29Sold $559.68Transaction Date : 10/13/23
-
Footnotes
-
-
Footnotes:#1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
-
M8,324 Shares After TransactionValue : $n/a$0.0Transaction Date : 09/13/23
-
Footnotes
-
-
Footnotes:#1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.#2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.